This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
20 Citations 5 Q&As
17 Citations 16 Q&As
19 Citations 15 Q&As
Facts about Nitric oxide synthase, inducible.
Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). Included in this iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on'Cys-247' implicated in regulation of the GAIT complicated activity and likely multiple objectives such as ANXA5, EZR, MSN and VIM (PubMed:25417112).
Human | |
---|---|
Gene Name: | NOS2 |
Uniprot: | P35228 |
Entrez: | 4843 |
Belongs to: |
---|
NOS family |
EC 1.14.13.39; Hepatocyte NOS; HEP-NOSPeptidyl-cysteine S-nitrosylase NOS2; Inducible NO synthase; Inducible NOS; iNOS; nitric oxide synthase 2, inducible; nitric oxide synthase 2A (inducible, hepatocytes); nitric oxide synthase, inducible; nitric oxide synthase, macrophage; NOS; NOS, type II; NOS2; NOS2A; NOS2ANOS type II
Mass (kDA):
131.117 kDA
Human | |
---|---|
Location: | 17q11.2 |
Sequence: | 17; NC_000017.11 (27756766..27800529, complement) |
Expressed in the liver, retina, bone cells and airway epithelial cells of the lung. Not expressed in the platelets.
Cytoplasm, cytosol. Localizes as discrete foci scattered throughout the cytosol and in the presence of SPSB1 and SPSB4, exhibits a more diffuse cytosolic localization.
If you're using a Boster Bio, you need to know the way that the marker functions. This guide will outline its history, enhance tests, and answer common questions. It will also provide suggestions for conducting an effective experiment. Every researcher has experienced problems during experiments. However many of the root causes can be resolved with the use of proper controls and troubleshooting guides.
There are many factors that must be considered when determining the best way to conduct your research using the NOS2 marker. Scientists employ Boster's high affinity primary antibodies. They are often cited. They are validated using ELISA, Immunohistochemistry, and Western Blotting. Optimizing your antibody with a variety of methods will ensure the best results. Check out these tips and tricks.
The iNOS protein contains eleven53 amino acids and interacts with several proteins, including FAD, FMN, and 6R-erythro-5,6,7-tetrahydrobiopterin. It is in contact with GAPDH and the SLC9A3R1 transnitrosylase complex. Its primary purpose is to inhibit the NOS transcription factor's activity.
A recent study showed co-expression of CD133 and NOS2 in human glioma tissue. Furthermore, a flow cytometry study showed that more than 90% of NOS2-positive cells also expressed CD133 and confirmed that this marker is also abundant in GSCs. While further studies are required to determine whether NOS2 is associated with the glioma's biology, these findings provide valuable data for the enhancement of GSCs.
While no research has been done to prove that NOS2-directed therapies are used to treat glioma in any way These results suggest that they are safe. GSCs may be inhibited by NOS2-directed drugs, which can make them more effective in treating glioma. The NOS2-directed treatments offer another benefit that they do not interfere with the immune system, which reduces the likelihood of relapse.
PMID: 7692964 by Sherman P.A., et al. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.
PMID: 7682706 by Geller D.A., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.
*Showing only the more recent 20. More publications can be found for each product on its corresponding product page